Home > Insider Trading > Filing (0001615774-15-001372)

Filing Details

Accession Number:: 0001615774-15-001372
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-06-04 17:24:38
Reporting Period:: 2015-06-02

Filing Date:: 2015-06-04
Accepted Time:: 2015-06-04 17:24:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1266806	Second Sight Medical Products Inc	EYES	Electromedical & Electrotherapeutic Apparatus (3845)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1625594	J. Robert Greenberg	12744 San Fernando Road, Bldg. 3 Sylmar CA 91342	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-06-02	78,153	$4.75	301,187	No	4	M	Direct
Common Stock	Disposition	2015-06-02	26,586	$13.96	275,231	No	4	F	Direct
Common Stock	Disposition	2015-06-02	78,153	$13.96	197,078	No	4	S	Direct
Common Stock	Acquisiton	2015-06-03	71,847	$4.75	268,925	No	4	M	Direct
Common Stock	Disposition	2015-06-03	24,167	$14.12	244,758	No	4	F	Direct
Common Stock	Disposition	2015-06-03	71,847	$14.12	172,911	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option	Acquisiton	2015-06-02	78,153	$0.00	78,153	$4.75
Common Stock	Option	Acquisiton	2015-06-03	71,847	$0.00	71,847	$4.75

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
71,847		2015-09-01	No	4	M	Direct
0		2015-09-01	No	4	M	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Option	$4.25	2017-01-01	125,000	125,000	Direct
Common Stock	Option	$4.75	2016-01-01	17,969	17,969	Direct
Common Stock	Option	$5.00	2016-05-01	8,223	8,223	Direct
Common Stock	Option	$5.00	2017-01-01	30,625	30,625	Direct
Common Stock	Option	$5.00	2018-02-01	23,750	30,625	Direct
Common Stock	Option	$5.00	2018-11-01	150,000	150,000	Direct
Common Stock	Option	$5.00	2019-02-01	33,750	33,750	Direct
Common Stock	Option	$5.00	2020-02-01	53,125	53,125	Direct
Common Stock	Option	$5.00	2020-02-01	50,625	50,625	Direct
Common Stock	Option	$5.00	2021-03-01	41,563	41,563	Direct
Common Stock	Option	$5.00	2022-03-01	29,063	29,063	Direct
Common Stock	Option	$5.00	2024-04-01	11,719	11,719	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2017-01-01	125,000	125,000	Direct
2016-01-01	17,969	17,969	Direct
2016-05-01	8,223	8,223	Direct
2017-01-01	30,625	30,625	Direct
2018-02-01	23,750	30,625	Direct
2018-11-01	150,000	150,000	Direct
2019-02-01	33,750	33,750	Direct
2020-02-01	53,125	53,125	Direct
2020-02-01	50,625	50,625	Direct
2021-03-01	41,563	41,563	Direct
2022-03-01	29,063	29,063	Direct
2024-04-01	11,719	11,719	Direct

Footnotes

Dr. Greenberg exercised 78,153 vested options reported as Option(C) on Form 3 filed with the SEC on November 18, 2014.
Dr. Greenberg tendered 26,586 shares of common stock to the Company in accordance with Rule 16b-3.
The fair market value on the day of the exercise.
The price reported in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.56 to $14.35, inclusive. The broker remitted $277,224 to the Company to cover withholding obligations. The reporting person undertakes to provide to the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These transactions were effected pursuant to planned sales under lock-up agreement entered into at the time of EYES IPO in November 2014, as approved by Board of EYES and the IPO underwriter and as further disclosed in the Company's final prospectus dated November 20, 2014.
Dr. Greenberg exercised 71,847 vested options reported as Option(C) on Form 3 filed with the SEC on November 18, 2014.
Dr. Greenberg tendered 24,167 shares of common stock to the Company in accordance with Rule 16b-3.
The price reported in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.50 to $14.64, inclusive. The broker remitted $351,333 to the Company to cover withholding obligations. The reporting person undertakes to provide to the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These transactions were effected pursuant to planned sales under lock-up agreement entered into at the time of EYES IPO in November 2014, as approved by Board of EYES and the IPO underwriter and as further disclosed in the Company's final prospectus dated November 20, 2014.
These are vested employee options currently exercisable.